Reperfusion of the acutely ischemic and infarcted human myocardium by Streptokinase/thrombolysis, by PTCA, by acute coronary artery surgery or a combination of all these methods has become increasingly utilized. Therefore, intraoperative myocardial protection of the ischemic myocardium to reduce the magnitude of the myocardial injury after coronary occlusion and reperfusion continues to be of the highest priority. Based on our work beginning in 1981, and continuing through the RO1 grant period, we have established more sophisticated techniques to evaluate local and global myocardial function after acute coronary occlusion and have begun to evaluate agents to either increase delivery of oxygen to ischemic myocardium or to interfere with the pathophysiologic effects of ischemia and reperfusion. In this grant period we will continue to pursue the concept of preparation of the ischemic area prior to reperfusion as well as treatment of the pathophysiologic effects of acute myocardial ischemia concurrently. We will evaluate 1) free oxygen radicals in both the acute and chronic ischemia models as well as the ex vivo preserved heart to define more precisely the mechanisms of their action, 2) thromboxane synthetase inhibitors in both the acute and chronic model, 3) calcium channel blockers and 4) agents that increase oxygen delivery to the ischemic myocardium, oxygenated crystalloid cardioplegia, blood cardioplegia and fluocarbons. In addition we intend to explore the use of other protective agents, particularly the oxygenated cardioplegic compounds applied distal to the site of coronary artery occlusion in our closed chest model simulating PTCA treatment of coronary occlusion. These studies will impact positively on the pre- hospital, invasive and operative treatment of acute MI, the leading cause of death in America. By reducing the total amount of infarcted muscle and improving regional myocardial function by these experimental approaches, the early and late mortality after myocardial infarction should be improved.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL033463-05
Application #
3345399
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1987-07-01
Project End
1990-12-31
Budget Start
1990-01-01
Budget End
1990-12-31
Support Year
5
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Byrne, J G; Appleyard, R F; Sun, S C et al. (1993) Cardiac-derived thromboxane A2. An initiating mediator of reperfusion injury? J Thorac Cardiovasc Surg 105:689-93
Byrne, J G; Appleyard, R F; Sun, S C et al. (1993) Thromboxane A2 mediates reperfusion injury after heart preservation. J Heart Lung Transplant 12:256-62
Byrne, J G; Appleyard, R F; Lee, C C et al. (1992) Controlled reperfusion of the regionally ischemic myocardium with leukocyte-depleted blood reduces stunning, the no-reflow phenomenon, and infarct size. J Thorac Cardiovasc Surg 103:66-71;discussion 71-2
Sun, S C; Appleyard, R; Masetti, P et al. (1992) Improved recovery of heart transplants by combined use of oxygen-derived free radical scavengers and energy enhancement. J Thorac Cardiovasc Surg 104:830-7
Austin, J C; Berrizbeitia, L D; Schoen, F J et al. (1988) Thromboxane synthetase inhibition reduces ventricular irritability after coronary occlusion and reperfusion. Am Heart J 115:505-9
Melendez, F J; Gharagozloo, F; Sun, S C et al. (1988) Effects of diltiazem cardioplegia on global function, segmental contractility, and the area of necrosis after acute coronary artery occlusion and surgical reperfusion. J Thorac Cardiovasc Surg 95:613-7
Gharagozloo, F; Melendez, F J; Hein, R A et al. (1988) The effect of oxygen free radical scavengers on the recovery of regional myocardial function after acute coronary occlusion and surgical reperfusion. J Thorac Cardiovasc Surg 95:631-6
Gharagozloo, F; Melendez, F J; Hein, R A et al. (1988) The effect of superoxide dismutase and catalase on the extended preservation of the ex vivo heart for transplantation. J Thorac Cardiovasc Surg 95:1008-13
Gharagozloo, F; Cohn, L H (1987) Measurement of coronary blood flow: a critical review. J Surg Res 42:314-27
Gharagozloo, F; Melendez, F J; Hein, R A et al. (1987) The effect of amino acid L-glutamate on the extended preservation ex vivo of the heart for transplantation. Circulation 76:V65-70

Showing the most recent 10 out of 11 publications